The purpose of this study is to evaluate two separate antiinflammatory products for the
relief of symptoms through suppression of the immunological and inflammatory response
following a mosquito bite. The investigators have selected ibuprofen gel as a NSAI
formulation and 0.05% Clobetasone butyrate as a steroid cream with their appropriate physical
matched placebo products.